AEPGX
Price
$64.70
Change
-$0.22 (-0.34%)
Updated
Sep 11 closing price
Net Assets
140.03B
LGGAX
Price
$67.92
Change
+$0.67 (+1.00%)
Updated
Sep 11 closing price
Net Assets
6.7B
Interact to see
Advertisement

AEPGX vs LGGAX

AEPGX vs LGGAX Comparison Chart in %
View a ticker or compare two or three
VS
AEPGX vs. LGGAX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPGX is a Buy and LGGAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPGX has more cash in the bank: 140B vs. LGGAX (6.7B). AEPGX pays higher dividends than LGGAX: AEPGX (2.48) vs LGGAX (1.45). AEPGX was incepted earlier than LGGAX: AEPGX (42 years) vs LGGAX (18 years). LGGAX (1.10) is less costly to investors than AEPGX (0.83). LGGAX is a more actively managed with annual turnover of: 68.00 vs. AEPGX (50.00). AEPGX (6%) and LGGAX (6%) have equivalent initial investment costs. AEPGX has a lower initial minimum investment than LGGAX: AEPGX (250) vs LGGAX (1000). AEPGX annual gain was more profitable for investors over the last year : 4.61 vs. LGGAX (-3.52). LGGAX return over 5 years is better than : 6.10 vs. AEPGX (-4.41).
AEPGXLGGAXAEPGX / LGGAX
Total Expense Ratio0.831.0678%
Annual Report Gross Expense Ratio0.831.1075%
Fund Existence42 years18 years-
Gain YTD6.9240.5031,376%
Front Load6%6%105%
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets140B6.7B2,090%
Annual Yield % from dividends2.481.45172%
Returns for 1 year4.61-3.52-131%
Returns for 3 years28.4732.5288%
Returns for 5 years-4.416.10-72%
Returns for 10 years48.08122.3339%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NFLX77.401.39
+1.83%
Netflix Inc.
CAI24.340.30
+1.25%
Caris Life Sciences Inc
ISBA39.360.45
+1.16%
Isabella Bank Corporation
MIRA0.77-0.02
-1.95%
MIRA Pharmaceuticals
LBRX44.63-1.62
-3.50%
LB Pharmaceuticals Inc